StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TECHNICHEM.BO$38.66-5.00%
Fair $38.66+0.0%

TECHNICHEM.BO

TECHNICHEM.BO

Basic Materials / Specialty ChemicalsBSE

$38.66

-2.14 (-5.00%)

Fairly Valued+0.0%Fair Value $38.66Fund rank 24/100 · Data gapFallback financials|
SA 40/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-53.1M · quality 46.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 12/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · TECHNICHEM.BOLocal privado en este navegador · TECHNICHEM.BO
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$670M

P/E

21.6x

↑

EV/EBITDA

7.3x

↓

ROE

8.8%

↑

Gross Margin

39.6%

↑

Debt/Equity

0.33

↑
52-Week Range$39
$33$66

TradingView lightweight chart

TECHNICHEM.BO price, volumen y niveles de valoración

Último $40.69Periodo -32.3%
Fair value: $38.66

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-5.4%

FCF CAGR

—

FCF margin

-24.4%

FCF / Net income

-3.44x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $567.8M · net income $40.3M · FCF $-138.4M

2022-FY → 2025-FY

Gross margin

39.6%+22.4% pts

Operating margin

12.1%+4.9% pts

Net margin

7.1%+2.0% pts

FCF margin

-24.4%-18.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$567.8M$567.8M$463.9M$503.6M$670.2M
Net Income$40.3M$40.3M$43.8M$17.3M$34.2M
EBITDA$80.0M$80.0M$98.4M$49.1M$61.0M
EPS3.033.032.531.001.97
Gross Margin39.6%39.6%46.2%22.0%17.2%
Operating Margin12.1%12.1%17.9%7.5%7.2%
Net Margin7.1%7.1%9.4%3.4%5.1%
Balance Sheet
Debt/Equity0.330.330.831.050.77
Current Ratio1.791.79———
Cash Flow
Free Cash Flow$-138.4M$-138.4M$1.1M$-53.1M$-42.0M
Returns
ROE8.8%8.8%22.7%11.6%26.0%
Valuation
P/E21.6021.60———
EV/EBITDA7.317.31———
P/B1.131.13———
Growth & Yield
Revenue Growth22.4%22.4%-7.9%-24.9%—
EPS Growth19.8%19.8%153.4%-49.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

4.2%

fácil

EPS terminal req.

$3.43

Spread vs growth

15.5%

5Y implied EPS CAGR

6.5%

razonable

EPS terminal req.

$4.15

Spread vs growth

13.3%

10Y implied EPS CAGR

8.2%

razonable

EPS terminal req.

$6.68

Spread vs growth

11.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -11.7%

Total return

-11.7%

Start / end P/E

18.2x → 13.4x

EPS bridge

2.53 → 3.03

Residual

-5.2%

EPS growth+19.8%
Multiple rerating-26.2%
Dividend+0.0%
Residual / FX / buybacks / cross-term-5.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.